Erlotinib Hexal

Erlotinib Hexal is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to cancer therapy.

Erlotinib Hexal is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' This medication is part of a broader category of cancer treatments known as tyrosine kinase inhibitors.

Common effects of Erlotinib Hexal may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss and nausea. These effects can vary in severity and may not affect everyone who takes the medication. It's important to monitor any changes in your health while using this drug.

Erlotinib Hexal should be handled with care, especially for those with pre-existing liver or kidney conditions. It is essential to follow the advice of a healthcare professional regarding its use. Pregnant women and those planning to become pregnant should discuss the potential risks with their doctor before starting this medication.

Erlotinib Hexal may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect how the body processes this medication.